Your browser doesn't support javascript.
loading
Retraction notice to "Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer" [Canc. Lett. 520 (2021) 385-399].
Taromi, Sanaz; Firat, Elke; Simonis, Alexander; Braun, Lukas M; Apostolova, Petya; Elze, Mirjam; Passlick, Bernward; Schumacher, Alicia; Lagies, Simon; Frey, Anna; Schmitt-Graeff, Annette; Burger, Meike; Schmittlutz, Katrin; Follo, Marie; von Elverfeldt, Dominik; Zhu, Xuekai; Kammerer, Bernd; Diederichs, Sven; Duyster, Justus; Manz, Markus G; Niedermann, Gabriele; Zeiser, Robert.
Afiliação
  • Taromi S; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; University Furtwangen, Faculty of Medical and Life Sciences, Campus VS-Schwenningen, Germany. Electronic address: sanaz.taromi@uniklinik-freiburg.de.
  • Firat E; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Germany.
  • Simonis A; Department of Medical Oncology and Hematology and Oncology, Zurich University and University Hospital Medical Center Zurich, Zurich, Switzerland.
  • Braun LM; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Apostolova P; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Elze M; Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Passlick B; Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Schumacher A; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Lagies S; Center for Biological Systems Analysis (ZBSA), University of Freiburg, Freiburg, Germany; Institute of Biology II, Albert-Ludwigs-University Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
  • Frey A; Department of Pathology, Freiburg University Medical Center, Albert-Ludwigs-University (ALU) Freiburg, Freiburg, Germany.
  • Schmitt-Graeff A; Department of Pathology, Freiburg University Medical Center, Albert-Ludwigs-University (ALU) Freiburg, Freiburg, Germany.
  • Burger M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; University Furtwangen, Faculty of Medical and Life Sciences, Campus VS-Schwenningen, Germany.
  • Schmittlutz K; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Follo M; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • von Elverfeldt D; Medical Physics, Freiburg University Medical Center, Faculty of Medicine, Albert-Ludwigs-University (ALU) Freiburg, Freiburg, Germany.
  • Zhu X; Shanghai Institute for Advanced Immunochemical Studies (SIAIS), Shanghai Tech University, Shanghai, China.
  • Kammerer B; Center for Biological Systems Analysis (ZBSA), University of Freiburg, Freiburg, Germany; Institute of Biology II, Albert-Ludwigs-University Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany; BIOSS Center for Biologica
  • Diederichs S; Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Duyster J; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Manz MG; Department of Medical Oncology and Hematology and Oncology, Zurich University and University Hospital Medical Center Zurich, Zurich, Switzerland.
  • Niedermann G; Department of Radiation Oncology, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium (DKTK), Freiburg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Zeiser R; Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; BIOSS Center for Biological Signalling Studies, University of Freiburg, Germany; Signalling Research Centres BIOSS and CIBSS - Centre for Integrative Biological Signalli
Cancer Lett ; 537: 215680, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35461758
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article